A citation-based method for searching scientific literature

Yanping Zhang, Hua Lu. Cancer Cell 2009
Times Cited: 411







List of co-cited articles
928 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The nucleolus under stress.
Séverine Boulon, Belinda J Westman, Saskia Hutten, François-Michel Boisvert, Angus I Lamond. Mol Cell 2010
633
24


Regulation of HDM2 activity by the ribosomal protein L11.
Marion A E Lohrum, Robert L Ludwig, Michael H G Kubbutat, Mary Hanlon, Karen H Vousden. Cancer Cell 2003
504
16

The multifunctional nucleolus.
François-Michel Boisvert, Silvana van Koningsbruggen, Joaquín Navascués, Angus I Lamond. Nat Rev Mol Cell Biol 2007
15

p53 and ribosome biogenesis stress: the essentials.
Lior Golomb, Sinisa Volarevic, Moshe Oren. FEBS Lett 2014
145
15


Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Megan J Bywater, Gretchen Poortinga, Elaine Sanij, Nadine Hein, Abigail Peck, Carleen Cullinane, Meaghan Wall, Leonie Cluse, Denis Drygin, Kenna Anderes,[...]. Cancer Cell 2012
369
15

Mdm2 promotes the rapid degradation of p53.
Y Haupt, R Maya, A Kazaz, M Oren. Nature 1997
15

Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.
Kaspar Burger, Bastian Mühl, Thomas Harasim, Michaela Rohrmoser, Anastassia Malamoussi, Mathias Orban, Markus Kellner, Anita Gruber-Eber, Elisabeth Kremmer, Michael Hölzel,[...]. J Biol Chem 2010
264
14


The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress.
Katherine E Sloan, Markus T Bohnsack, Nicholas J Watkins. Cell Rep 2013
175
13

Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
Denis Drygin, Amy Lin, Josh Bliesath, Caroline B Ho, Sean E O'Brien, Chris Proffitt, Mayuko Omori, Mustapha Haddach, Michael K Schwaebe, Adam Siddiqui-Jain,[...]. Cancer Res 2011
348
13

Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
X Zhou, Q Hao, J Liao, Q Zhang, H Lu. Oncogene 2013
116
13

Ribosome biogenesis in cancer: new players and therapeutic avenues.
Joffrey Pelletier, George Thomas, Siniša Volarević. Nat Rev Cancer 2018
282
13

Nucleolar stress with and without p53.
Allison James, Yubo Wang, Himanshu Raje, Raphyel Rosby, Patrick DiMario. Nucleus 2014
164
12

Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress.
Sladana Bursać, Maja Cokarić Brdovčak, Martin Pfannkuchen, Ines Orsolić, Lior Golomb, Yan Zhu, Chen Katz, Lilyn Daftuar, Kristina Grabušić, Iva Vukelić,[...]. Proc Natl Acad Sci U S A 2012
135
12

Ribosomopathies: human disorders of ribosome dysfunction.
Anupama Narla, Benjamin L Ebert. Blood 2010
515
12

Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.
Mu-Shui Dai, Shelya X Zeng, Yetao Jin, Xiao-Xin Sun, Larry David, Hua Lu. Mol Cell Biol 2004
384
12


How common are extraribosomal functions of ribosomal proteins?
Jonathan R Warner, Kerri B McIntosh. Mol Cell 2009
472
10

Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Yanping Zhang, Gabrielle White Wolf, Krishna Bhat, Aiwen Jin, Theresa Allio, William A Burkhart, Yue Xiong. Mol Cell Biol 2003
425
10

Ribosomal proteins: functions beyond the ribosome.
Xiang Zhou, Wen-Juan Liao, Jun-Ming Liao, Peng Liao, Hua Lu. J Mol Cell Biol 2015
324
10

Ribosomopathies: There's strength in numbers.
Eric W Mills, Rachel Green. Science 2017
206
10

MYC as a regulator of ribosome biogenesis and protein synthesis.
Jan van Riggelen, Alper Yetil, Dean W Felsher. Nat Rev Cancer 2010
540
9

Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide.
Zhen Shi, Kotaro Fujii, Kyle M Kovary, Naomi R Genuth, Hannes L Röst, Mary N Teruel, Maria Barna. Mol Cell 2017
283
9


CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.
Hong Xu, Marco Di Antonio, Steven McKinney, Veena Mathew, Brandon Ho, Nigel J O'Neil, Nancy Dos Santos, Jennifer Silvester, Vivien Wei, Jessica Garcia,[...]. Nat Commun 2017
246
9

A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.
Karita Peltonen, Laureen Colis, Hester Liu, Rishi Trivedi, Michael S Moubarek, Henna M Moore, Baoyan Bai, Michelle A Rudek, Charles J Bieberich, Marikki Laiho. Cancer Cell 2014
161
9

Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction.
Stefano Fumagalli, Alessandro Di Cara, Arti Neb-Gulati, Francois Natt, Sandy Schwemberger, Jonathan Hall, George F Babcock, Rosa Bernardi, Pier Paolo Pandolfi, George Thomas. Nat Cell Biol 2009
243
9

Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
Aiwen Jin, Koji Itahana, Kevin O'Keefe, Yanping Zhang. Mol Cell Biol 2004
288
9

Regulation of p53 stability by Mdm2.
M H Kubbutat, S N Jones, K H Vousden. Nature 1997
9

Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.
Krishna P Bhat, Koji Itahana, Aiwen Jin, Yanping Zhang. EMBO J 2004
200
8

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.
Benjamin L Ebert, Jennifer Pretz, Jocelyn Bosco, Cindy Y Chang, Pablo Tamayo, Naomi Galili, Azra Raza, David E Root, Eyal Attar, Steven R Ellis,[...]. Nature 2008
652
8

Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress.
Emilien Nicolas, Pascaline Parisot, Celina Pinto-Monteiro, Roxane de Walque, Christophe De Vleeschouwer, Denis L J Lafontaine. Nat Commun 2016
98
8



Ribosomal protein S7 is both a regulator and a substrate of MDM2.
Yan Zhu, Masha V Poyurovsky, Yingchun Li, Lynn Biderman, Joachim Stahl, Xavier Jacq, Carol Prives. Mol Cell 2009
161
8

The first 30 years of p53: growing ever more complex.
Arnold J Levine, Moshe Oren. Nat Rev Cancer 2009
8

Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.
Masato Sasaki, Kohichi Kawahara, Miki Nishio, Koshi Mimori, Ryunosuke Kogo, Koichi Hamada, Bunsho Itoh, Jia Wang, Yukako Komatsu, Yong Ryoul Yang,[...]. Nat Med 2011
131
8

Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.
Shilpee Dutt, Anupama Narla, Katherine Lin, Ann Mullally, Nirmalee Abayasekara, Christine Megerdichian, Frederick H Wilson, Treeve Currie, Arati Khanna-Gupta, Nancy Berliner,[...]. Blood 2011
279
8

Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
Sladana Bursac, Maja Cokaric Brdovcak, Giulio Donati, Sinisa Volarevic. Biochim Biophys Acta 2014
101
7

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.
Maria Barna, Aya Pusic, Ornella Zollo, Maria Costa, Nadya Kondrashov, Eduardo Rego, Pulivarthi H Rao, Davide Ruggero. Nature 2008
292
7

Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress.
Annapina Russo, Giulia Russo. Int J Mol Sci 2017
68
10


Nucleolar function and size in cancer cells.
M Derenzini, D Trerè, A Pession, L Montanaro, V Sirri, R L Ochs. Am J Pathol 1998
158
7

Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
X Zhou, Q Hao, Q Zhang, J-M Liao, J-W Ke, P Liao, B Cao, H Lu. Cell Death Differ 2015
32
21

Making ribosomes.
Alessandro Fatica, David Tollervey. Curr Opin Cell Biol 2002
398
7

RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance.
Yong Liu, Chad Deisenroth, Yanping Zhang. Trends Cancer 2016
40
17

Does the ribosome translate cancer?
Davide Ruggero, Pier Paolo Pandolfi. Nat Rev Cancer 2003
726
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.